PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24953979-7	2014	Novel, non-quinazoline, EGFR inhibitors, that also target EGFR activating and resistance (T790M) mutations, are currently under clinical development.	Quinazolines	11-22	epidermal growth factor receptor	Homo sapiens	24-28